Examination of Vitamin D Levels in Genital Wart in Women of Shahrood
Subject Areas : Journal of Animal Biology
Nilofar Fathi pour
1
,
Elahe Jalali
2
*
1 - Department of Medicine, Sh.C., Islamic Azad University, Shahroud, Iran
2 - Department of Chemistry, Da.C., Islamic Azad University, Damghan Iran
Keywords: Vitamin D deficiency, Genital warts, Cervical cancer, Contraceptive pill, HPV,
Abstract :
Since vitamin D deficiency has been stated as a cause of various cancers in different studies and its role in the immune system to fight human papillomavirus in the body has been discussed in particular, we decided to conduct a study entitled "Investigating Vitamin D Levels in Genital Wart Infection." HPV 6 and 11 are the cause of 80% of genital warts, and women infected with human papillomavirus have visible warts. Types 16, 18, 31, 33, 35, and 45 are associated with high-grade cervical dysplasia and cervical cancer. This cross-sectional study was conducted on patients who had referred to the gynecological and obstetric clinics of Shahroud as outpatients due to genital wart infection. The target population included 50 patients with genital wart infection and the data collection tools were observation, interview, questionnaire, and test. After extracting all the data, the results were statistically analyzed using SPSS 23 software. Serum vitamin D levels were measured in all patients. 84% of patients with genital warts had vitamin D deficiency, which is a high figure. Also, in those who used hormonal contraceptives, this figure was 80%, in those who had sexually transmitted infections, 93.3%, and in those who used tobacco, 88.9%. We observed a high percentage of vitamin D deficiency in people with genital warts. (84%) It seems that vitamin D deficiency can be effective in the possible development of genital warts. As a result, vitamin D supplements are recommended to correct vitamin D deficiency in young and sexually active women.
.
1. Okunade KS. Human papillomavirus and cervical cancer. J Obstetr Gynaecol. 2020;40(5):602-608.
2. Jensen JE, Becker GL, Jackson JB, Rysavy MB. Human papillomavirus and associated cancers: a review. Viruses. 2024;16(5):680.
3. Cheng L, Wang Y, Du J. Human papillomavirus vaccines: an updated review. Vaccines. 2020;8(3):391.
4. Kore VB, Anjankar A. A comprehensive review of treatment approaches for cutaneous and genital warts. Cureus. 2023;15(10).
5. Khalili SM, Rafiei EH, Havaei M, Alizadeh L, Ghahremani F, Keshavarz Z, et al. Relationship between human papillomavirus and serum vitamin D levels: a systematic review. BMC Infect Dis. 2024;24(1):80.
6. Gupta A, Villa A, Feldman S, Citow B, Sroussi H. Site and sex-specific differences in the effect of vitamin D on human papillomavirus infections: analyses of NHANES 2009–2014. Sex Transm Infect. 2021;97(1):75-76.
7. Song ZY, Yao Q, Zhuo Z, Ma Z, Chen G. Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis. Endocr Connect. 2018;7(12):R294-r303.
8. Xin Y, Wang H, Wang Y, Xu W, Teng G, Han F, et al. CCL20 mediates the anti-tumor effect of vitamin D3 in p38MAPK/NF-κB signaling in colitis-associated carcinogenesis. Eur J Cancer Prev. 2021;30(1):76-83.
9. Hernández-Rangel AE, Hernandez-Fuentes GA, Montes-Galindo DA, Sanchez-Ramirez CA, Cabrera-Licona A, Martinez-Fierro ML, et al. Vitamin D3 (calcitriol) monotherapy decreases tumor growth, increases survival, and correlates with a low neutrophil-to-lymphocyte ratio in a murine HPV-16-related cancer model. Biomedicines. 2024;12(6):1357.
10. Kim S-I, Chaurasiya S, Sivanandam V, Kang S, Park AK, Lu J, et al. Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer. Mol Ther-Oncolytics. 2022;24:864-72.
11. Wei D, Wang L, Zuo X, Bresalier RS. Vitamin D: promises on the horizon and challenges ahead for fighting pancreatic cancer. Cancers. 2021;13(11):2716.
12. Rizwan M, Cheng K, Gang Y, Hou Y, Wang C. Immunomodulatory Effects of Vitamin D and Zinc on Viral Infection. Biol Trace Elem Res. 2025;203(1):1-17.
13. Gaudet M, Plesa M, Mogas A, Jalaleddine N, Hamid Q, Al Heialy S. Recent advances in vitamin D implications in chronic respiratory diseases. Respir Res. 2022;23(1):252.
14. Seraphin G, Rieger S, Hewison M, Capobianco E, Lisse TS. The impact of vitamin D on cancer: A mini review. The J Steroid Biochem and Mole Biol. 2023;231:106308.
15. Khosravi-Boroujeni H, Sarrafzadegan N, Sadeghi M, Roohafza H, Ng SK, Pourmogaddas A, et al. Prevalence and Trends of Vitamin D Deficiency among Iranian Adults: A Longitudinal Study from 2001-2013. J Nutr Sci Vitaminol (Tokyo). 2017;63(5):284-90.
16. Marzban M, Kalantarhormozi M, Mahmudpour M, Ostovar A, Keshmiri S, Darabi AH, et al. Prevalence of vitamin D deficiency and its associated risk factors among rural population of the northern part of the Persian Gulf. BMC Endocr Disord. 2021;21(1):219.
17. Ferrari FA, Magni F, Bosco M, Biancotto G, Zorzato PC, Laganà AS, et al., editors. The role of micronutrients in human papillomavirus infection, cervical dysplasia, and neoplasm. Healthcare. 2023: MDPI.
18. Shalaby ME, Hasan MS, Elshorbagy MS, Abo Raya AR, Elsaie ML. Diagnostic and therapeutic implications of vitamin D deficiency in patients with warts: a case‐controlled study. J Cosmet Dermatol. 2022;21(3):1135-42.
19. AlSabak H, Al‐Hattab M, Al-Rammahi M, Al‐Dhalimi M. The efficacy of intralesional vitamin D3 injection in the treatment of cutaneous warts: A clinical therapeutic trial study. Skin Res Technol. 2023;29(8):e13442.
20. Goodarzi A, Farshidzadeh M, Roohaninasab M, Atefi N, Behrangi E. Assessment of serum vitamin D level in patients with cutaneous warts: a case-control study. Iran J Dermatol. 2020;23(2):64-71.